Viemed Healthcare, Inc.

NASDAQ:VMD

9.51 (USD) • At close November 11, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q3
Revenue 58.00454.96550.59352.14149.40243.31139.55637.50835.75933.3132.25531.96229.28527.39928.41631.20233.44742.85423.80621.44823.52522.54720.44318.48917.16315.50814.11113.54812.45110.90110.0289.1917.925
Cost of Revenue 23.63322.4520.79119.58918.8417.20515.55214.61214.10812.9212.51212.310.9049.77410.67412.02413.99416.9278.2537.2056.3185.6865.0414.8444.1014.1853.5593.3623.143.0422.7697.1931.608
Gross Profit 34.37132.51529.80232.55330.56226.10624.00422.89621.65120.3919.74319.66218.38117.62517.74219.17819.45325.92715.55314.24317.20716.86115.40213.64513.06211.32310.55210.1869.3117.8597.2591.9986.317
Gross Profit Ratio 0.5930.5920.5890.6240.6190.6030.6070.610.6050.6120.6120.6150.6280.6430.6240.6150.5820.6050.6530.6640.7310.7480.7530.7380.7610.730.7480.7520.7480.7210.7240.2170.797
Reseach & Development Expenses 0.7570.7580.750.6690.5930.7580.780.7220.670.6720.6320.6120.5760.5830.3390.3950.2430.2710.1740.2030.2080.2030.2340000000000
General & Administrative Expenses 028.12326.24625.43925.10722.03421.15318.48918.98618.80717.08115.54514.56214.1215.81613.57514.78417.62411.72811.08214.34514.27810.1958.6618.3777.3696.2748.4483.924.5463.33300
Selling & Marketing Expenses 0-0.22100.64000-1.31700000000000-0.047000.0470.0810.0810.0620.044-0.1360.0360.0650.03500
SG&A 26.67127.90226.24626.07925.10722.03421.15318.48918.98618.80717.08115.54514.56214.1215.81613.57514.78417.62411.72811.08214.34514.27810.2428.7428.4587.4316.3188.3123.9564.6113.3680.8395.455
Other Expenses 0-0.5630.026-0.0270.040.0020.159-0.0270.2340.223-0.218-1.3040.1790.1750.179-0.155000-0.037-0.027-0.025-0.024-0.03-0.033-0.0070.20600.1020.0980.09600
Operating Expenses 27.42829.22327.38526.77526.07823.08822.09219.18419.8919.49917.49514.85315.31714.87816.33413.81515.2118.112.10711.49614.74614.61910.718.8728.5867.5556.5248.4184.0584.7093.4640.0595.846
Operating Income 5.6283.2922.2045.7774.2062.9011.9343.5341.4691.0012.2484.6652.9192.6641.3325.2674.0412.8594.6152.6582.2672.1324.6924.7734.4763.7684.0281.7685.2533.153.7951.8020.505
Operating Income Ratio 0.0970.060.0440.1110.0850.0670.0490.0940.0410.030.070.1460.10.0970.0470.1690.1210.30.1940.1240.0960.0950.230.2580.2610.2430.2850.130.4220.2890.3780.1960.064
Total Other Income Expenses Net -0.129-1.047-0.146-0.561-0.0080.020.0840.050.0420.5560.2590.3150.1860.1480.144-0.041-0.1825.0741.142-0.0890.606-0.378-2.374-1.57-1.98-1.335-1.64-1.615-1.225-1.354-1.3090.067-0.131
Income Before Tax 5.4992.2452.1215.2164.2393.0582.0183.5841.5111.3882.5075.0553.1752.8121.4615.2223.94512.7664.432.4463.0111.8442.2923.1732.4592.3662.3410.1043.9611.7152.4111.8690.374
Income Before Tax Ratio 0.0950.0410.0420.10.0860.0710.0510.0960.0420.0420.0780.1580.1080.1030.0510.1670.1180.2980.1860.1140.1280.0820.1120.1720.1430.1530.1660.0080.3180.1570.240.2030.047
Income Tax Expense 1.5940.7680.5181.6431.320.7280.5011.1460.4560.4210.7450.9681.3861.246-0.2230.1511.141-6.6460.1870.0580.0510.0240.1380.1270.0350.0670.0470.13-0.057-0.0580.0751.1190.014
Net Income 3.8781.4681.6033.4772.9192.331.5172.4381.0550.9671.7624.0871.7891.5661.6845.0712.80419.4124.2432.3882.961.822.1543.0462.4242.3662.341-0.0264.0181.7732.4112.9880.388
Net Income Ratio 0.0670.0270.0320.0670.0590.0540.0380.0650.030.0290.0550.1280.0610.0570.0590.1630.0840.4530.1780.1110.1260.0810.1050.1650.1410.1530.166-0.0020.3230.1630.240.3250.049
EPS 0.10.0380.040.0930.0750.0620.040.0640.0280.020.0450.10.050.040.040.130.070.50.110.060.080.040.050.0810.060.060.06-0.0010.110.0470.0640.0220.065
EPS Diluted 0.0950.0360.040.0890.0710.0580.0380.0620.0270.020.0440.10.040.040.040.120.070.480.110.060.070.030.050.0770.060.060.06-0.0010.110.0470.0640.0220.065
EBITDA 5.5959.6018.76911.88910.7298.3416.6524.1315.9665.0765.9685.1866.2623.1854.0935.6226.8714.9855.5494.7492.6543.5816.0925.955.4484.6614.7692.5075.9153.7624.3252.2510.83
EBITDA Ratio 0.0960.1750.1730.2280.2170.1930.1680.110.1670.1520.1850.1620.2140.1160.1440.180.2050.1160.2330.2210.1130.1590.2980.3220.3170.3010.3380.1850.4750.3450.4310.2450.105